Equitec Proprietary Markets Has Trimmed At&T (Put) (T) Holding By $1.49 Million; Last Week SORRENTO TECH COM USD0.001 (ROKA) Coverage

April 21, 2018 - By Linda Rogers

SORRENTO TECH INC COM USD0.001 (NASDAQ:ROKA) Logo

Equitec Proprietary Markets Llc decreased At&T Inc (Put) (T) stake by 83.09% reported in 2017Q4 SEC filing. Equitec Proprietary Markets Llc sold 39,300 shares as At&T Inc (Put) (T)’s stock declined 10.37%. The Equitec Proprietary Markets Llc holds 8,000 shares with $311,000 value, down from 47,300 last quarter. At&T Inc (Put) now has $225.19 billion valuation. The stock decreased 0.43% or $0.15 during the last trading session, reaching $34.67. About 32.45M shares traded or 18.79% up from the average. AT&T Inc. (NYSE:T) has declined 15.88% since April 21, 2017 and is downtrending. It has underperformed by 27.43% the S&P500.

Among 5 analysts covering Roka Bioscience (NASDAQ:ROKA), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Roka Bioscience had 9 analyst reports since August 14, 2015 according to SRatingsIntel. Leerink Swann maintained it with “Outperform” rating and $4 target in Friday, August 14 report. The rating was initiated by Roth Capital with “Buy” on Tuesday, December 13. Zacks downgraded SORRENTO TECH INC COM USD0.001 (NASDAQ:ROKA) on Tuesday, August 25 to “Hold” rating. Leerink Swann downgraded SORRENTO TECH INC COM USD0.001 (NASDAQ:ROKA) rating on Monday, March 7. Leerink Swann has “Market Perform” rating and $1 target. The rating was upgraded by Zacks to “Hold” on Tuesday, September 8. The company was initiated on Tuesday, December 13 by TH Capital. See SORRENTO TECH INC COM USD0.001 (NASDAQ:ROKA) latest ratings:

The stock decreased 2.97% or $0.02 during the last trading session, reaching $0.65. About 242,292 shares traded or Infinity% up from the average. SORRENTO TECH INC COM USD0.001 (NASDAQ:ROKA) has 0.00% since April 21, 2017 and is . It has underperformed by 11.55% the S&P500.

Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. The company has market cap of $. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single and integrated platform. It currently has negative earnings. The firm also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies.

Analysts await AT&T Inc. (NYSE:T) to report earnings on April, 25 after the close. They expect $0.87 EPS, up 17.57% or $0.13 from last year’s $0.74 per share. T’s profit will be $5.65 billion for 9.96 P/E if the $0.87 EPS becomes a reality. After $0.78 actual EPS reported by AT&T Inc. for the previous quarter, Wall Street now forecasts 11.54% EPS growth.

Equitec Proprietary Markets Llc increased Time Warner Inc (Call) (NYSE:TWX) stake by 203,200 shares to 263,800 valued at $24.13M in 2017Q4. It also upped Monsanto Co New (Put) (NYSE:MON) stake by 67,300 shares and now owns 193,300 shares. Monsanto Co New (Call) (NYSE:MON) was raised too.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.26, from 1.17 in 2017Q3. It turned negative, as 67 investors sold T shares while 714 reduced holdings. 125 funds opened positions while 589 raised stakes. 3.09 billion shares or 7.58% less from 3.34 billion shares in 2017Q3 were reported. Mountain Pacific Advisers Inc Id stated it has 0.03% of its portfolio in AT&T Inc. (NYSE:T). Bank & Trust Of The West reported 58,090 shares. Meridian Inv Counsel Incorporated owns 85,894 shares. Folger Nolan Fleming Douglas Cap Management reported 0.51% stake. Planning Advsrs Ltd Liability reported 14,208 shares or 0.19% of all its holdings. Argent Tru holds 1.23% or 118,437 shares in its portfolio. The Delaware-based Ashford Cap Mngmt has invested 0.05% in AT&T Inc. (NYSE:T). Longer holds 2.21% or 68,090 shares. Orrstown Serv Inc invested in 21,155 shares. New England Rech And Mngmt reported 15,255 shares. Boston And Management reported 0.69% of its portfolio in AT&T Inc. (NYSE:T). Trillium Asset Management Ltd Liability Corp holds 0.02% or 7,032 shares in its portfolio. Menora Mivtachim Limited, a Israel-based fund reported 1.30 million shares. North Amer Mngmt Corp holds 1.06% or 178,485 shares. Ramsay Stattman Vela Price Incorporated holds 98,451 shares.

Among 31 analysts covering AT&T Inc. (NYSE:T), 12 have Buy rating, 1 Sell and 18 Hold. Therefore 39% are positive. AT&T Inc. had 79 analyst reports since July 27, 2015 according to SRatingsIntel. As per Friday, April 13, the company rating was maintained by Barclays Capital. Wells Fargo maintained AT&T Inc. (NYSE:T) rating on Friday, March 23. Wells Fargo has “Outperform” rating and $40 target. The firm earned “Buy” rating on Monday, November 14 by Deutsche Bank. The rating was maintained by Deutsche Bank on Wednesday, October 25 with “Hold”. The rating was downgraded by Moffet Nathanson on Friday, April 1 to “Sell”. The company was maintained on Thursday, April 7 by Jefferies. The rating was maintained by S&P Research on Friday, August 14 with “Buy”. Wells Fargo maintained AT&T Inc. (NYSE:T) on Wednesday, April 12 with “Outperform” rating. As per Tuesday, April 5, the company rating was initiated by Macquarie Research. Bank of America maintained it with “Neutral” rating and $40 target in Friday, February 2 report.

AT&T Inc. (NYSE:T) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>